Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
about
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imagingDesign, synthesis, and miniemulsion polymerization of new phosphonate surfmers and application studies of the resulting nanoparticles as model systems for biomimetic mineralization and cellular uptake.Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo.Multifunctional plasmonic nanorattles for spectrum-guided locoregional therapy.Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis.Cubic magnetically guided nanoaggregates for inhalable drug delivery: in vitro magnetic aerosol deposition studyPotential of magnetic nanoparticles for targeted drug deliveryInhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?pH-sensitive micelles self-assembled from polymer brush (PAE-g-cholesterol)-b-PEG-b-(PAE-g-cholesterol) for anticancer drug delivery and controlled release.Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.In vitro and in vivo chemo-phototherapy of magnetic TiO2 drug delivery system formed by pH-sensitive coordination bond.Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide.Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier.Doxorubicin-loaded cholic acid-polyethyleneimine micelles for targeted delivery of antitumor drugs: synthesis, characterization, and evaluation of their in vitro cytotoxicity.Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.
P2860
Q30827270-96CBD1CC-492D-447C-9CAD-230655DB54F2Q33906003-C5AD74E4-5FCC-4755-A041-83F42D8F231AQ34213530-0C4CB523-D383-47DA-BF4B-76E9DD07D2A5Q34786445-D879A79F-7423-4215-B5DE-AE74193FB6EFQ35024524-71F85F73-BA98-4FF3-BA93-058CDB02DD88Q36297030-149FACFB-0552-4399-97E0-FEB846EAD81CQ37126447-E5E6500F-B8CF-4B61-A2C2-120FA83A9AE1Q37194054-CA3FD1AE-CCAE-4B99-9BC6-B75814E460CFQ37663392-B033A5AE-8E3A-4F45-A129-BB929C2929F1Q37722704-992178EB-28AE-4F61-820B-EEFFC5942CECQ38115981-973EDD10-93C1-40B7-833E-7ED673288847Q38849605-407FF79B-6664-4EC7-BF87-A710341E0F94Q39146745-6E15DA3A-C0CD-4F8E-A0DF-05A818530C41Q41682922-D8C16813-B5CE-4623-8ABE-02FA89AE158CQ42201143-E536427C-0951-46C6-9594-15485157534EQ42534599-1DBC2452-359A-4907-B028-61871ED0721FQ43138300-55F58924-4628-477E-98CE-150160538B9B
P2860
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@en
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@nl
type
label
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@en
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@nl
prefLabel
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@en
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@nl
P2093
P1433
P1476
Superhigh-magnetization nanoca ...... or magnetic targeting therapy.
@en
P2093
Cheng-Keng Chuang
Heng-Chang Chuang
Hung-Wei Yang
Kun-Lung Chuang
Rung-Ywan Tsai
See-Tong Pang
Tsong-Long Hwang
Ying-Hsu Chang
Yu-Sun Chang
P304
P356
10.1016/J.BIOMATERIALS.2011.08.014
P50
P577
2011-08-27T00:00:00Z